Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial

被引:3
作者
Howard, Robert [1 ]
Cort, Elizabeth [1 ]
Rawlinson, Charlotte [1 ]
Wiegand, Martin [2 ]
Downey, Anne [2 ]
Lawrence, Vanessa [3 ]
Banerjee, Sube [4 ]
Bentham, Peter [5 ]
Fox, Chris [6 ]
Harwood, Rowan [7 ]
Hunter, Rachel [2 ]
Livingston, Gill [1 ]
Moniz-Cook, Esme [8 ]
Panca, Monica [2 ]
Raczek, Malgorzata [9 ]
Ivenso, Chineze [10 ]
Russell, Gregor [11 ]
Thomas, Alan [12 ]
Wilkinson, Philip [13 ]
Freemantle, Nicholas [14 ]
Gould, Rebecca [1 ]
机构
[1] UCL, Div Psychiat, London, England
[2] UCL, Priment Clin Trials Unit, London, England
[3] Kings Coll London, David Goldberg Ctr H1 01, London, England
[4] Univ Plymouth, Plymouth, Devon, England
[5] Birmingham & Solihull NHS Trust, Birmingham, England
[6] Univ East Anglia, Norwich, Norfolk, England
[7] Univ Nottingham, Queens Med Ctr, Nottingham, England
[8] Univ Hull, Kingston Upon Hull, England
[9] Brighton & Sussex Sch Med, Brighton, E Sussex, England
[10] Aneurin Bevan NHS Trust, St Cadocs Hosp, Newport, Wales
[11] Bradford Dist Care Fdn Trust, Bradford, England
[12] Univ Newcastle, Campus Ageing & Vital, Newcastle Upon Tyne, England
[13] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England
[14] UCL, Comprehens Clin Trials Unit, London, England
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; clinical trial; depression; mood; problem adaptation therapy; psychological; psychotherapy; MINI-MENTAL-STATE; ANXIETY; PEOPLE; SCALE;
D O I
10.1002/alz.13766
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: Trials of effectiveness of treatment options for depression in dementia are an important priority. METHODS: Randomized controlled trial to assess adapted Problem Adaptation Therapy (PATH) for depression in mild/moderate dementia caused by Alzheimer's disease. RESULTS: Three hundred thirty-six participants with mild or moderate dementia, >7 on Cornell Scale for Depression in Dementia (CSDD), randomized to adapted PATH or treatment as usual. Mean age 77.0 years, 39.0% males, mean Mini-Mental State Examination 21.6, mean CSDD 12.9. For primary outcome (CSDD at 6 months), no statistically significant benefit with adapted PATH on the CSDD (6 months: -0.58; 95% CI -1.71 to 0.54). The CSDD at 3 months showed a small benefit with adapted PATH (-1.38; 95% CI -2.54 to -0.21) as did the EQ-5D (-4.97; 95% CI -9.46 to -0.48). DISCUSSION: An eight-session course of adapted PATH plus two booster sessions administered within NHS dementia services was not effective treatment for depression in people with mild and moderate dementia. Future studies should examine the effect of more intensive and longer-term therapy.
引用
收藏
页码:2990 / 2999
页数:10
相关论文
共 50 条
[31]   An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial [J].
Johansson, Peter ;
Westas, Mats ;
Andersson, Gerhard ;
Alehagen, Urban ;
Brostrom, Anders ;
Jaarsma, Tiny ;
Mourad, Ghassan ;
Lundgren, Johan .
JMIR MENTAL HEALTH, 2019, 6 (10)
[32]   Effects of a Taiwanese Adaptation of the Group Cognitive Stimulation Therapy Program on Mild-To-Moderate Dementia: A Quasi-Experimental Trial [J].
Huang, Chih-Kun ;
Lee, Pai-Lin ;
Lee, Hsiao-Han .
JOURNAL OF GERONTOLOGICAL SOCIAL WORK, 2024, 67 (08) :1227-1241
[33]   A Culturally Adapted Cognitive Behavioral Therapy Group: A Randomized Controlled Trial [J].
Young, Daniel K. W. ;
Yat-nam, Petrus N. G. .
RESEARCH ON SOCIAL WORK PRACTICE, 2022, 32 (04) :415-425
[34]   Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial [J].
Dubois, Bruno ;
Lopez-Arrieta, Jesus ;
Lipschitz, Stanley ;
Triantafyllos, Doskas ;
Spiru, Luiza ;
Moroz, Svitlana ;
Venger, Olena ;
Vermersch, Patrick ;
Moussy, Alain ;
Mansfield, Colin D. D. ;
Hermine, Olivier ;
Tsolaki, Magda .
ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
[35]   Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial [J].
Bruno Dubois ;
Jesús López-Arrieta ;
Stanley Lipschitz ;
Triantafyllos Doskas ;
Luiza Spiru ;
Svitlana Moroz ;
Olena Venger ;
Patrick Vermersch ;
Alain Moussy ;
Colin D. Mansfield ;
Olivier Hermine ;
Magda Tsolaki .
Alzheimer's Research & Therapy, 15
[36]   Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomized and placebo-controlled trial [J].
Akhondzadeh, S ;
Noroozian, M ;
Mohammadi, M ;
Ohadinia, S ;
Jamshidi, AH ;
Khani, M .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (01) :53-59
[37]   Effect of Music Therapy on Anxiety and Depression in Patients with Alzheimer's Type Dementia: Randomised, Controlled Study [J].
Guetin, S. ;
Portet, F. ;
Picot, M. C. ;
Pommie, C. ;
Messaoudi, M. ;
Djabelkir, L. ;
Olsen, A. L. ;
Cano, M. M. ;
Lecourt, E. ;
Touchon, J. .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (01) :36-46
[38]   Randomized Controlled Trial of Memantine in Dementia Associated with Parkinson's Disease [J].
Leroi, Iracema ;
Overshott, Ross ;
Byrne, E. Jane ;
Daniel, Emily ;
Burns, Alistair .
MOVEMENT DISORDERS, 2009, 24 (08) :1217-1221
[39]   Art therapy as an adjuvant treatment for depression in elderly women: a randomized controlled trial [J].
Ciasca, Eliana C. ;
Ferreira, Rita C. ;
Santana, Carmen L. A. ;
Forlenza, Orestes V. ;
dos Santos, Glenda D. ;
Brum, Paula S. ;
Nunes, Paula V. .
REVISTA BRASILEIRA DE PSIQUIATRIA, 2018, 40 (03) :256-263
[40]   Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial [J].
Moreno, MD .
CLINICAL THERAPEUTICS, 2003, 25 (01) :178-193